Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a government funding lapse notice at the top of the page. Updated the site version from v3.4.0 to v3.4.1, removing the previous version reference.
    Difference
    0.7%
    Check dated 2026-02-04T10:29:36.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    UI changes add a glossary toggle and color-coded highlights for additions (green) and deletions (red). The page shows a new revision label (v3.4.0) replacing the previous version (v3.3.4).
    Difference
    0.8%
    Check dated 2026-01-28T06:27:47.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added Study Status entries dated 2026-01-12 and 2026-01-09 with Revision: v3.3.4; removed the 2025-10-03 entry and Revision: v3.3.3 from the history.
    Difference
    0.4%
    Check dated 2026-01-14T03:21:29.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:21:45.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the Record History; these are site revision notes and do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:16.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page.
    Difference
    0.6%
    Check dated 2025-11-18T07:12:39.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.